Forian (FORA) Stock Price, News & Analysis

Company Overview

Forian (NASDAQ: FORA) is a global regulatory technology company offering cloud-native software solutions for enterprise risk management and financial crime compliance. The company’s platform enables financial institutions to automate and streamline regulatory reporting, transaction surveillance, market risk measurement and client onboarding processes. By consolidating data across multiple asset classes and jurisdictions, Forian helps organizations maintain compliance with evolving regulatory frameworks such as MiFID II, EMIR, Dodd-Frank, FATCA and local AML/KYC requirements.

Founded in 2013 as RegTek Solutions, the business rebranded to Forian in 2023 following a period of strategic expansion into complementary risk and compliance offerings. In December 2022, the company completed a business combination with a special purpose acquisition company (SPAC), providing additional capital to accelerate product development and global growth. Since its inception, Forian has invested in modular SaaS architecture, enabling clients to select specific capabilities—from transaction reporting and position keeping to real-time trade surveillance and counterparty screening—while scaling easily as regulatory demands evolve.

Forian serves a diverse client base that includes banks, brokerage firms, asset managers, custodians and corporate treasuries across North America, Europe, Asia-Pacific and other key financial centers. The company maintains offices and delivery centers in major regions, offering regional support and managed services to address local regulatory nuances. Its cloud deployment model supports both public and private cloud environments, ensuring data security, resiliency and compliance with regional data residency requirements.

Led by a senior management team with deep expertise in financial services, regulatory affairs and enterprise technology, Forian continues to expand its suite of services through strategic partnerships and ongoing product innovation. By focusing on automated regulatory reporting, advanced surveillance analytics and comprehensive financial crime compliance, the company aims to help clients reduce operational risk, improve transparency and drive cost efficiencies in their compliance programs.

Key Stats

• Today's Range: $2.15 to $2.16
• 50-Day Range: $2.03 to $2.16
• 52-Week Range: $1.64 to $2.71
• Volume: 14,536 shs
• Average Volume: 24,077 shs
• Market Capitalization: $67.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Forian Stock Analysis - MarketRank™

Forian scored higher than 17% of companies evaluated by MarketBeat, and ranked 788th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Forian has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Forian has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Forian is -23.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Forian is -23.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.16% of the float of Forian has been sold short.

Short Interest Ratio / Days to Cover

Forian has a short interest ratio ("days to cover") of 1.51, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Forian has recently decreased by 17.25%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Forian does not currently pay a dividend.

Dividend Growth

Forian does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.96

News Sentiment

Forian has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Forian this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for FORA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Forian insiders have not sold or bought any company stock.

Percentage Held by Insiders

24.80% of the stock of Forian is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

19.25% of the stock of Forian is held by institutions.

FORA Stock Analysis - Frequently Asked Questions

How have FORA shares performed this year?

Forian's stock was trading at $2.12 at the beginning of 2026. Since then, FORA stock has increased by 1.7% and is now trading at $2.1550.

How were Forian's earnings last quarter?

Forian Inc. (NASDAQ:FORA) released its quarterly earnings results on Friday, March, 27th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.01 by $0.07. The firm earned $7.96 million during the quarter, compared to analyst estimates of $7.70 million.

Who are Forian's major shareholders?

Forian's top institutional shareholders include Diversified Investment Strategies LLC (0.15%). Insiders that own company stock include Max C Wygod, Stanley S Trotman Jr and Martin J Wygod.
View institutional ownership trends.

How do I buy shares of Forian?

Shares of FORA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Forian own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Forian investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM), Iamgold (IAG), XPENG (XPEV) and AbCellera Biologics (ABCL).

Company Calendar

• Last Earnings: 3/27/2026
• Today: 5/05/2026
• Next Earnings (Confirmed): 5/12/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:FORA
• CIK: 1829280
• Web: forian.com
• Phone: +17203285372
• Fax: N/A
• Employees: 140
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $30.26 million
• Price / Sales: 2.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 31,209,000
• Free Float: N/A
• Market Cap: $67.26 million
• Optionable: Optionable
• Beta: 0.93